CDNA
CareDx Inc
Get Prediction
Get AI stock predictions on your device
About This Company
CareDx develops molecular tests for assessing the immune system and treating kidney and heart diseases. The company specializes in transplantation, offering tests to evaluate donor-recipient compatibility for organ transplants, monitor graft status, and detect signs of rejection. CareDx also develops diagnostic tests for cardiomyopathies and hereditary diseases. The company collaborates with clinics worldwide.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
